A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Summary

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label extension (OLE) phase.

Timeline

Start

2024-06-20

Primary completion

2026-03-12

Completion

2026-03-12

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications